Conference series LLC LTD hosted the “3rd International Conference on Antibodies and Bio Therapeutics & B2B” during November 08-09, 2017 at Renaissance Las Vegas Hotel, 3400 Paradise Road, Las Vegas, USA with the theme “Global Update on Antibodies, Bio Therapeutics: Research, Development and Market” was a great success, where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Antibodies and Microbiology Researchers, Scientists, Students and Leaders in Antibodies, Bio Therapeutics research field, Immunology, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

Antibody Engineering

Antibodies: Medical Applications

Immunotherapy and Immune Checkpoints

Protein Engineering

Antibody Drug Therapy

Anti-Cancer Antibodies

Bio Therapeutics: Novel Formulation and Delivery Approaches

The conference was embarked with an opening ceremony followed by a series of lectures delivered by Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

Dr William George Whitford, GE Health Care, USA

Dr Robert M Stroud, University of California San Francisco, USA

Dr A Keith Dunker, Indiana University, USA

Dr Abdellah Salhi, University of Essex, UK

Conference Sessions Chairs:

Dr William Whitford, GE Health Care, USA 

Dr Itai Benhar, Tel Aviv University, Israel

Dr Christopher H Gray, CRUK Beatson Institute, UK

Dr Karen Bunting, Albumedix Ltd, UK

We congratulate Geoff P Lin-Cereghino from University of the Pacific, USA for winning Best Poster Award for the topic “Characterization of the Bgs13 protein’s role in the super-secretion of recombinant peptides in the yeast Pichia pastoris”.

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Antibodies 2017, Conference Series LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, “4th Antibodies, Antibiotics and Bio Therapeutics Congress” to be held during December 05-06, 2018 at Chicago, USA.

Let us meet again @ Antibodies-2018